Publications by authors named "Jennifer L Clarke"

50Publications

Post-ER Stress Biogenesis of Golgi Is Governed by Giantin.

Cells 2019 12 13;8(12). Epub 2019 Dec 13.

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8121631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953117PMC
December 2019

Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy.

J Neurooncol 2020 Jan 14;146(1):71-78. Epub 2019 Nov 14.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03336-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939141PMC
January 2020

Attitudes toward fertility and fertility preservation in women with glioma.

Neurooncol Pract 2019 May 26;6(3):218-225. Epub 2018 Sep 26.

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656302PMC
May 2019

Short term dynamics of the sputum microbiome among COPD patients.

PLoS One 2018 8;13(3):e0191499. Epub 2018 Mar 8.

University of Nebraska, Department of Food Science & Technology, Lincoln, NE, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191499PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843169PMC
June 2018

Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine.

Biomedicines 2016 Oct 31;4(4). Epub 2016 Oct 31.

Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Avenue, M-391, San Francisco, CA 94143-0628, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biomedicines4040024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344267PMC
October 2016

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.

Cancer Chemother Pharmacol 2017 03 23;79(3):603-610. Epub 2017 Feb 23.

Division of Neuro-oncology, Department of Neurological Surgery, University of California, San Francisco (UCSF), 505 Parnassus Avenue M779, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3247-3DOI Listing
March 2017

EnsCat: clustering of categorical data via ensembling.

BMC Bioinformatics 2016 Sep 15;17(1):380. Epub 2016 Sep 15.

Department of Statistics, University of Nebraska-Lincoln, Lincoln, NE, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-016-1245-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025633PMC
September 2016

Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.

Neuro Oncol 2017 01 9;19(1):78-88. Epub 2016 Jun 9.

Department of Radiation Oncology, University of California San Francisco, San Francisco, California (D.R.R., S.A.L., A.L., M.A.G., P.K.S., D.A.H.-K.); Division of Neuropathology, Department of Pathology, University of California San Francisco, San Francisco, California (D.A.S., T.T.); Department of Neurology, University of California San Francisco, San Francisco, California (J.L.C.); Department of Neurologic Surgery, University of California San Francisco, San Francisco, California (J.L.C., M.W.M., M.S.B.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193017PMC
January 2017

: meningioma.

Neurooncol Pract 2016 Jun 13;3(2):120-134. Epub 2016 Jan 13.

Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA (S.E.F.); Department of Radiology, Mayo Clinic, Rochester, MN, USA (D.R.J., T.J.K.); Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA (F.G.B.); Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA (P.K.B.); Department of Neurology and Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA (J.L.C.); Department of Neurology, Karl Landsteiner University Clinic, St Pölten, Austria (S.O.); Department of Internal Medicine, Medical University, Vienna, CCC, Austria (M.P.); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA (A.R.); Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (S.S.); Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA (P.V.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668267PMC
June 2016

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.

J Neurooncol 2016 Jan;126(1):193-200

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, 450 Brookline Ave, D1622, Boston, MA, 02215-5418, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1959-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826306PMC
January 2016

: newly diagnosed glioblastoma.

Neurooncol Pract 2015 Sep 21;2(3):106-121. Epub 2015 Jul 21.

Department of Neurology and Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota (D.R.J.); Department of Radiation Oncology, University of California, San Francisco, California (S.E.F.); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (C.G., A.R.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (T.J.K.); Department of Neurological Surgery, University of California, San Francisco, California (P.V.T.); Department of Neurology and Department of Neurological Surgery, University of California, San Francisco, California (J.L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668273PMC
September 2015

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.

Neurosurgery 2015 Aug;62 Suppl 1:160-5

*Department of Neurological Surgery, ‡Department of Epidemiology and Biostatistics, and §Department of Neurology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260825PMC
August 2015

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Neurosurgery 2015 Aug;77(2):248-53; discussion 253

Departments of *Neurological Surgery, ‡Epidemiology and Biostatistics, and §Neurology, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506198PMC
August 2015

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma.

Case Rep Radiol 2015 22;2015:731361. Epub 2015 Feb 22.

Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Avenue, M-391, San Francisco, CA 94143-0628, USA ; Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, Room 779 M, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/731361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352456PMC
March 2015

Bevacizumab and other targeted agents in the upfront treatment of glioblastoma.

Semin Radiat Oncol 2014 Oct;24(4):273-8

Department of Neurology, University of California, San Francisco, CA; Department of Neurological Surgery, University of California, San Francisco, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2014.06.002DOI Listing
October 2014

Standardization and quality assurance of radiation therapy volumes for adults with high-grade gliomas.

Semin Radiat Oncol 2014 Oct;24(4):259-64

Department of Radiation Oncology, University of California, San Francisco, (UCSF), School of Medicine, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2014.06.009DOI Listing
October 2014

Familial gliomas: cases in two pairs of brothers.

J Neurooncol 2015 Jan 11;121(1):135-40. Epub 2014 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., Rm M779, San Francisco, CA, 94143-0112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1611-2DOI Listing
January 2015

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.

Neuro Oncol 2014 Sep 26;16(9):1255-62. Epub 2014 Mar 26.

Department of Neurological Surgery, University of California, San Francisco, California (S.J.H., J.D.R., A.M.M., J.L.C., M.D.P., S.M.C., M.S.B., A.D., N.A.B.); Department of Epidemiology and Biostatistics, University of California, San Francisco, California (A.M.M.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136897PMC
September 2014

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Neuro Oncol 2014 Jan 12;16(2):274-9. Epub 2013 Dec 12.

Corresponding Author: Andrew T. Parsa, MD, PhD, Professor and Chair, Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL 60611.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895386PMC
January 2014

Relationship of glioblastoma multiforme to the subventricular zone is associated with survival.

Neuro Oncol 2013 Jan 24;15(1):91-6. Epub 2012 Oct 24.

Department of Radiology, University of California, San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534420PMC
January 2013

Neoplastic myelopathy.

Semin Neurol 2012 Apr 8;32(2):137-45. Epub 2012 Sep 8.

Division of Neuro-oncology, Department of Neurology, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1322584DOI Listing
April 2012

Leptomeningeal metastasis from systemic cancer.

Continuum (Minneap Minn) 2012 Apr;18(2):328-42

University of California, San Francisco, 400 Parnassus Avenue, A-808, Box 0372, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.CON.0000413661.58045.e7DOI Listing
April 2012

Neuroimaging: diagnosis and response assessment in glioblastoma.

Cancer J 2012 Jan-Feb;18(1):26-31

Department of Neurological Surgery, Division of Neuro-Oncology, University of California-San Francisco, San Francisco, CA 94143-0372, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e318244d7c8DOI Listing
May 2012

Primary central nervous system lymphoma.

Handb Clin Neurol 2012 ;105:517-27

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-53502-3.00006-9DOI Listing
April 2012

Conditional probability of survival in patients with newly diagnosed glioblastoma.

J Clin Oncol 2011 Nov 3;29(31):4175-80. Epub 2011 Oct 3.

Biometric Research Branch, National Cancer Institute, National Institute of Health, Room 8124, Executive Plaza North, 6130 Executive Blvd, Rockville, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.32.4343
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.32.4343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208537PMC
November 2011

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

Neuro Oncol 2011 Dec 24;13(12):1364-9. Epub 2011 Aug 24.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223088PMC
December 2011

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.

Neurosurgery 2012 Feb;70(2):361-70

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e3182314f9dDOI Listing
February 2012

Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.

Neuro Oncol 2010 Mar 21;12(3):274-82. Epub 2009 Dec 21.

Brain Tumor Research Center, Department of Neurological Surgery, University of California-San Francisco, 400 Parnassus Avenue, Room A-808, Box 0372, San Francisco, California 94143-2167, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nop034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940590PMC
March 2010

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.

J Neurooncol 2010 Sep 10;99(2):283-6. Epub 2010 Feb 10.

Department of Neurology and Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-010-0128-6
Publisher Site
http://dx.doi.org/10.1007/s11060-010-0128-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973736PMC
September 2010

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging.

Curr Neurol Neurosci Rep 2009 May;9(3):241-6

Department of Neurological Surgery, Division of Neuro-oncology, University of California-San Francisco, 400 Parnassus Avenue, A-808, Box 0372, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-009-0035-4DOI Listing
May 2009

External validation of the ICH score.

Neurocrit Care 2004 ;1(1):53-60

Department of Neurology, University of California, San Francisco, and San Francisco General Hospital, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/NCC:1:1:53DOI Listing
January 2006